CannabisNewsBreaks

FridayAug 10, 2018 3:05 pm

CannabisNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) to Provide Ultra-Purified Cannabis Extracts Through White Label Agreement

Sunniva (CSE: SNN) (OTCQX: SNNVF) has penned a white label services agreement to provide Cannabis Strategic Ventures, Inc. (OTC: NUGS) with top-quality cannabis extracts for its Pure Organix™ brand. In discussing the venture, Sunniva CEO Tony Holler stated, “As one of the highest quality producers in the marketplace, we believe we are in an excellent position to provide brand product manufacturing services for Cannabis Strategic. Both of our firms share the vision of becoming leaders in providing clean, medical grade cannabis products to consumers.” To view the full article, visit http://cnw.fm/9hK1r About Cannabis Strategic Ventures, Inc. Cannabis Strategic Ventures is…

Continue Reading

FridayAug 10, 2018 11:57 am

CannabisNewsBreaks – Why Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is “One to Watch”

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF) is a premium food and beverage company that develops foods, beverages and supplements infused with cannabidiol (“CBD”) for global distribution. An article discussing the company reads: “Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold. … Encapsulated CBD is infused into functional beverages, food and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health and wellness conditions. Phivida tests every…

Continue Reading

ThursdayAug 09, 2018 3:22 pm

CannabisNewsBreaks – Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) and Canopy Rivers Corp. File Early Warning Report Regarding the Close of LiveWell Qualifying Transaction

Canopy Growth Corp. (TSX: WEED) (NYSE: CGC), together with Canopy Rivers Corp., announced in a recent news release that they have filed an early warning report in connection with the closing of the qualifying transaction of LiveWell Canada Inc., formerly Percy Street Capital Corporation, under National Instrument 62-103. Per the transaction, the two companies received a total of 17,589,552 common shares of Livewell in exchange for their common shares of LiveWell Foods Canada Inc. Canopy Growth holds 11,726,364 common shares and Canopy Rivers holds 5,863,188 common shares. Prior to the transaction, neither company held any common shares or convertible securities…

Continue Reading

ThursdayAug 09, 2018 9:32 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Announces Agreement with Shopify Inc. (NYSE: SHOP) (TSX: SHOP)

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) this morning announced that it has selected Shopify Inc. (NYSE: SHOP) (TSX: SHOP) to create an innovative ecommerce platform for the delivery of medical and future adult-use organic cannabis worldwide. “We are pleased to announce this agreement with ecommerce giant Shopify,” Csaba Reider, president of TGOD, stated in the news release. “We see tremendous value in this relationship and Shopify will play an instrumental role in our ability to rapidly scale and provide our premium organic cannabis to global markets.” To view the full press…

Continue Reading

ThursdayAug 09, 2018 9:27 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Inks LOI with Pharmaflorx for the Supply of Cannabis Oils and Isolates

Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has signed a Letter of Intent (“LOI”) with Pharmaflorx Ltd. ("PFX") for the supply of cannabis oils and isolates. PFX is a privately-held late-stage Access to Cannabis for Medical Purposes Regulations ("ACMPR") applicant located in Gatineau, Quebec. Per the update, Pivot will acquire a minimum of 1,000 kg/year of cannabis oils or isolates from PFX to manufacture its patented portfolio of biocannabis products. Pivot intends to supply both the Canadian and European Union markets with its suite of patented products following receipt of fitting licenses where regulations…

Continue Reading

WednesdayAug 08, 2018 10:55 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Unveils Medicinal Cannabis Division’s First Product Development Program

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced the first product development program of the company’s newly created medicinal cannabis division, which will focus on the development of cannabinoids as a preventative treatment for anxiety disorders using PreveCeutical’s proprietary Sol-gel delivery platform. Per the update, the goal of the medical cannabis division’s program is to “create an effective therapy for anxiety that can be administered subtly and infrequently, addressing concerns of currently available treatments for anxiety disorders.” According to data from the Mayo Clinic, common approaches to treating anxiety, such as the prescription…

Continue Reading

WednesdayAug 08, 2018 9:51 am

CannabisNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Advances $1M Capital Tranche to ezGreen Compliance

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that it has advanced $1 million to its investee company, ezGreen Compliance, which offers a state-of-the-art enterprise compliance and point-of-sale software solution for licensed medical cannabis dispensaries and cultivators. Per the update, FinCanna has now advanced $1.75 million of the $3 million to be funded under the royalty agreement, which entitles FinCanna to a perpetual royalty equal to 10 percent of consolidated gross revenues of ezGreen, subject to certain buy-back options. “The ezGreen team is committed to creating state of…

Continue Reading

WednesdayAug 08, 2018 9:34 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Enters Binding LOI with HOPE Cannabis Products

Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that its wholly-owned subsidiary, Pivot Naturals LLC, has entered into a binding Letter of Intent (“LOI”) with Healthcare Options for Patients Enterprises LLC, dba HOPE Cannabis Products ("HOPE"). HOPE is fully licensed to manufacture, distribute and sell cannabis products in Nevada, offering products such as effect-based vape cartridges, syringes, micro-dosed oral sprays, pre-rolls, infused pre-rolls, infused cold brew coffee and infused lemonade. Per the LOI, HOPE will manufacture and distribute Pivot Naturals' product line in Nevada and Pivot will manufacture and distribute HOPE's product line in California. Definitive agreements,…

Continue Reading

TuesdayAug 07, 2018 3:27 pm

CannabisNewsBreaks – The Flowr Corp.’s Chairman and Chief Strategist Discusses Company Activities and Outlook in Kahner Global Interview

Steve Klein, the chairman and chief strategist of The Flowr Corp., provided an overview of the company's activities and outlook during an interview that was posted on Kahner Global's website. Flowr is a Canadian licensed producer that focuses primarily on premium flower production. "On the financial side, we're working to complete a process that will lead to us being listed on the TSX Ventures exchange. That should be done by September. On the operating side, we're completing the build out of Kelowna this year, including the Hawthorne research center.  It's about 20% operational now but we need to finish it…

Continue Reading

TuesdayAug 07, 2018 10:21 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Reports Successful Delivery of Nicotine Within Minutes in Edible Nicotine Study

Drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning announced that within minutes after dosing in an animal in vivo study, it has successfully delivered nicotine in an edible form into blood plasma. Per the update, Lexaria's DehydraTECH™ technology delivered nicotine with 90.2% greater delivery than the concentration-matched control formulation by the 10-minute mark and substantially greater absorption levels than the control formulation at all time intervals in the study. The company contracted a third-party laboratory to conduct the study which concentrated on detailed analysis of absorption over a 60-minute period. Lexaria's in vitro laboratory, in vivo…

Continue Reading